scispace - formally typeset
Open AccessJournal ArticleDOI

Antiviral activities of type I interferons to SARS-CoV-2 infection.

TLDR
The sensitivity of SARS-CoV-2 to recombinant human interferons α and β (IFNα/β) is reported and the potential efficacy of human Type I IFN in suppressing Sars- CoV- 2 infection is demonstrated, which could inform future treatment options for COVID-19.
About
This article is published in Antiviral Research.The article was published on 2020-07-01 and is currently open access. It has received 345 citations till now. The article focuses on the topics: Vero cell.

read more

Citations
More filters
Journal ArticleDOI

Characteristics of SARS-CoV-2 and COVID-19

TL;DR: The basic virology of SARS-CoV-2 is described, including genomic characteristics and receptor use, highlighting its key difference from previously known coronaviruses.
Journal ArticleDOI

Immunology of COVID-19: Current State of the Science.

Nicolas Vabret, +87 more
- 16 Jun 2020 - 
TL;DR: The current state of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute to disease severity and death are summarized.
Journal ArticleDOI

Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19.

TL;DR: The recent progress in the understanding of both type I and type III IFN-mediated innate antiviral responses against human coronaviruses is described and the potential use of IFNs as a treatment strategy for COVID-19 is discussed.
Journal ArticleDOI

Evasion of Type I Interferon by SARS-CoV-2.

TL;DR: Insight is provided on SARS-CoV-2 evasion of IFN-I response and its potential impact on viral transmission and pathogenesis.
Journal ArticleDOI

Interplay between SARS-CoV-2 and the type I interferon response.

TL;DR: The potential benefits of a well-timed IFN-I treatment and strategies to boost pDC-mediated IFN responses during the early stages of viral infection are discussed.
References
More filters
Journal ArticleDOI

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

TL;DR: Hospitalised COVID-19 patients are frequently elderly subjects with co-morbidities receiving polypharmacy, all of which are known risk factors for d
Journal ArticleDOI

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.

TL;DR: Binformatics analysis on a virus genome from a patient with 2019-nCoV infection and compared it with other related coronavirus genomes provide the basis for starting further studies on the pathogenesis, and optimizing the design of diagnostic, antiviral and vaccination strategies for this emerging infection.
Journal ArticleDOI

The severe acute respiratory syndrome.

TL;DR: The concerted and coordinated response that contained SARS is a triumph for global public health and provides a new paradigm for the detection and control of future emerging infectious disease threats.
Journal ArticleDOI

A diverse range of gene products are effectors of the type I interferon antiviral response

TL;DR: It is shown that different viruses are targeted by unique sets of ISGs, and that each viral species is susceptible to multiple antiviral genes, which together encompass a range of inhibitory activities.
Journal ArticleDOI

Interferons, interferon‐like cytokines, and their receptors

TL;DR: This review summarizes the history of the purification of human IFNs and the key aspects of the current state of knowledge of humanIFN genes, proteins, and receptors and provides some new insights into the development of these proteins as major elements of innate immunity.
Related Papers (5)
Trending Questions (1)
Is SARS COV 2 RNA worse than Covid 19?

These results suggest that SARS-CoV-2 is more sensitive than many other human pathogenic viruses, including SARS-CoV.